Search research articles
Contact Us
Filters
Showing results (171-180 of 182) with videos related to
Page
of 19
Sort By:
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
Suvankar Pal, Jeremy Chataway, Robert Swingler, et al.
Journal of Neurology
|
July 10, 2025
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases
Annabelle Coleman, Alexiane Touzé, Mena Farag, et al.
Brain : a Journal of Neurology
|
March 24, 2017
Clinical and genetic characterization of leukoencephalopathies in adults
David S Lynch, Anderson Rodrigues Brandão de Paiva, Wei Jia Zhang, et al.
Neurology
|
August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis
Sarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Brain Communications
|
December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
Charis Wong, Maria Stavrou, Elizabeth Elliott, et al.
Neuroradiology
|
June 6, 2026
An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI
Zoe Mendelsohn, Ferran Prados, Giuseppe Pontillo, et al.
BMJ Neurology Open
|
September 12, 2024
Brain reserve and physical disability in secondary progressive multiple sclerosis
Nevin John, Yingtong Li, Floriana De Angelis, et al.
BMJ Open
|
February 1, 2023
Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus
Charis Wong, Jenna M Gregory, Jing Liao, et al.
Lancet (London, England)
|
October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial
Jeremy Chataway, Thomas Williams, James Blackstone, et al.
The Lancet. Neurology
|
September 20, 2025
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Xavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 182) with videos related to
Sort By:
Page
of 19
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
Suvankar Pal, Jeremy Chataway, Robert Swingler, et al.
Journal of Neurology
|
July 10, 2025
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases
Annabelle Coleman, Alexiane Touzé, Mena Farag, et al.
Brain : a Journal of Neurology
|
March 24, 2017
Clinical and genetic characterization of leukoencephalopathies in adults
David S Lynch, Anderson Rodrigues Brandão de Paiva, Wei Jia Zhang, et al.
Neurology
|
August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis
Sarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Brain Communications
|
December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
Charis Wong, Maria Stavrou, Elizabeth Elliott, et al.
Neuroradiology
|
June 6, 2026
An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI
Zoe Mendelsohn, Ferran Prados, Giuseppe Pontillo, et al.
BMJ Neurology Open
|
September 12, 2024
Brain reserve and physical disability in secondary progressive multiple sclerosis
Nevin John, Yingtong Li, Floriana De Angelis, et al.
BMJ Open
|
February 1, 2023
Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus
Charis Wong, Jenna M Gregory, Jing Liao, et al.
Lancet (London, England)
|
October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial
Jeremy Chataway, Thomas Williams, James Blackstone, et al.
The Lancet. Neurology
|
September 20, 2025
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Xavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, et al.
Page
of 19